JP7430297B2 - N-アルキルアミノ酸、およびn-アルキルアミノ酸を含むペプチドの製造方法 - Google Patents

N-アルキルアミノ酸、およびn-アルキルアミノ酸を含むペプチドの製造方法 Download PDF

Info

Publication number
JP7430297B2
JP7430297B2 JP2023568520A JP2023568520A JP7430297B2 JP 7430297 B2 JP7430297 B2 JP 7430297B2 JP 2023568520 A JP2023568520 A JP 2023568520A JP 2023568520 A JP2023568520 A JP 2023568520A JP 7430297 B2 JP7430297 B2 JP 7430297B2
Authority
JP
Japan
Prior art keywords
ester
peptide
group
amino acid
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023568520A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023127869A1 (https=
JPWO2023127869A5 (https=
Inventor
志央 小宮
増▲華▼ 侯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of JPWO2023127869A1 publication Critical patent/JPWO2023127869A1/ja
Publication of JPWO2023127869A5 publication Critical patent/JPWO2023127869A5/ja
Priority to JP2024011686A priority Critical patent/JP2024052694A/ja
Application granted granted Critical
Publication of JP7430297B2 publication Critical patent/JP7430297B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B61/00Other general methods
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/062General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2023568520A 2021-12-28 2022-12-27 N-アルキルアミノ酸、およびn-アルキルアミノ酸を含むペプチドの製造方法 Active JP7430297B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024011686A JP2024052694A (ja) 2021-12-28 2024-01-30 N-アルキルアミノ酸、およびn-アルキルアミノ酸を含むペプチドの製造方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2021214900 2021-12-28
JP2021214900 2021-12-28
JP2022168608 2022-10-20
JP2022168608 2022-10-20
PCT/JP2022/048135 WO2023127869A1 (ja) 2021-12-28 2022-12-27 N-アルキルアミノ酸、およびn-アルキルアミノ酸を含むペプチドの製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024011686A Division JP2024052694A (ja) 2021-12-28 2024-01-30 N-アルキルアミノ酸、およびn-アルキルアミノ酸を含むペプチドの製造方法

Publications (3)

Publication Number Publication Date
JPWO2023127869A1 JPWO2023127869A1 (https=) 2023-07-06
JPWO2023127869A5 JPWO2023127869A5 (https=) 2024-01-19
JP7430297B2 true JP7430297B2 (ja) 2024-02-09

Family

ID=86999039

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023568520A Active JP7430297B2 (ja) 2021-12-28 2022-12-27 N-アルキルアミノ酸、およびn-アルキルアミノ酸を含むペプチドの製造方法
JP2024011686A Pending JP2024052694A (ja) 2021-12-28 2024-01-30 N-アルキルアミノ酸、およびn-アルキルアミノ酸を含むペプチドの製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024011686A Pending JP2024052694A (ja) 2021-12-28 2024-01-30 N-アルキルアミノ酸、およびn-アルキルアミノ酸を含むペプチドの製造方法

Country Status (11)

Country Link
US (1) US20250197450A1 (https=)
EP (1) EP4414374A4 (https=)
JP (2) JP7430297B2 (https=)
KR (1) KR102844018B1 (https=)
AR (1) AR128119A1 (https=)
AU (1) AU2022428318A1 (https=)
CA (1) CA3237911A1 (https=)
IL (1) IL312468A (https=)
MX (1) MX2024008002A (https=)
TW (1) TW202342495A (https=)
WO (1) WO2023127869A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI787670B (zh) 2011-12-28 2022-12-21 日商中外製藥股份有限公司 具有環狀部之胜肽化合物及其醫藥組成物
WO2018225851A1 (ja) 2017-06-09 2018-12-13 中外製薬株式会社 N-置換アミノ酸を含むペプチドの合成方法
EP3878836B1 (en) 2018-11-07 2025-07-23 Chugai Seiyaku Kabushiki Kaisha O-substituted serine derivative production method
PE20221323A1 (es) 2019-11-07 2022-09-09 Chugai Pharmaceutical Co Ltd Compuesto de peptidos ciclicos que tiene accion inhibidora de kras
TW202309065A (zh) 2021-05-07 2023-03-01 日商中外製藥股份有限公司 包含n-取代胺基酸殘基之環狀化合物的製造方法
CA3256645A1 (en) 2022-05-06 2025-04-23 Chugai Seiyaku Kabushiki Kaisha CYCLIC COMPOUND HAVING A SELECTIVE KRAS INHIBITORY EFFECT ON HRAS AND NRAS
EP4596567A1 (en) 2022-11-01 2025-08-06 Chugai Seiyaku Kabushiki Kaisha Method for removing dibenzofulvene or dibenzofulvene derivative
JPWO2024143514A1 (https=) 2022-12-28 2024-07-04
WO2025070753A1 (ja) 2023-09-28 2025-04-03 中外製薬株式会社 混合酸無水物法を用いたペプチド化合物の製造方法
CN121889409A (zh) 2023-12-27 2026-04-17 中外制药株式会社 用于使用独立型缩合剂生产肽化合物的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015656A1 (en) 1998-09-10 2000-03-23 Holland Sweetener Company V.O.F. Process for the preparation of neotame
WO2021090855A1 (ja) 2019-11-07 2021-05-14 中外製薬株式会社 Kras阻害作用を有する環状ペプチド化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7232758B2 (ja) 2017-06-09 2023-03-06 中外製薬株式会社 膜透過性の高い環状ペプチド化合物、及びこれを含むライブラリ
WO2018225851A1 (ja) * 2017-06-09 2018-12-13 中外製薬株式会社 N-置換アミノ酸を含むペプチドの合成方法
JP7568510B2 (ja) * 2018-11-30 2024-10-16 中外製薬株式会社 ペプチド化合物、またはアミド化合物の脱保護法および固相反応における脱樹脂方法、並びにペプチド化合物の製造方法
WO2020122182A1 (ja) 2018-12-12 2020-06-18 中外製薬株式会社 分子内水素結合可能な官能基を有するアミノ酸とそれらのアミノ酸を含むペプチド化合物、およびそれらの製造方法
KR20210139366A (ko) 2019-03-15 2021-11-22 추가이 세이야쿠 가부시키가이샤 방향족 아미노산 유도체의 제조 방법

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000015656A1 (en) 1998-09-10 2000-03-23 Holland Sweetener Company V.O.F. Process for the preparation of neotame
WO2021090855A1 (ja) 2019-11-07 2021-05-14 中外製薬株式会社 Kras阻害作用を有する環状ペプチド化合物

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEN D. et al.,Selective N-terminal functionalization of native peptides and proteins,Chem. Sci.,2017年,Vol.8,pp.2717-2722
HAN Y. et al.,A Novel, One-Pot Reductive Alkylation of Amines by S-Ethyl Thioesters Mediated by Triethylsilane and Sodium Triacetoxyborohydride in the Presence of Palladium on Carbon,J. Org. Chem.,1999年,Vol.64,pp.1972-1978
IKAWA T. et al.,Selective N-alkylation of amines using nitriles under hydrogenation conditions: facile synthesis of secondary and tertiary amines,Org. Biomol. Chem.,2012年,Vol.10,pp.293-304
SAJIKI H. et al.,Reductive and Catalytic Monoalkylation of Primary Amines Using Nitriles as an Alkylating Reagent,ORGANIC LETTERS,2004年,Vol.6, No.26,pp.4977-4980

Also Published As

Publication number Publication date
KR20240113971A (ko) 2024-07-23
EP4414374A1 (en) 2024-08-14
JPWO2023127869A1 (https=) 2023-07-06
IL312468A (en) 2024-06-01
WO2023127869A1 (ja) 2023-07-06
JP2024052694A (ja) 2024-04-11
AR128119A1 (es) 2024-03-27
EP4414374A4 (en) 2025-11-19
TW202342495A (zh) 2023-11-01
US20250197450A1 (en) 2025-06-19
CA3237911A1 (en) 2023-07-06
MX2024008002A (es) 2024-07-12
AU2022428318A1 (en) 2024-05-16
KR102844018B1 (ko) 2025-08-07

Similar Documents

Publication Publication Date Title
JP7430297B2 (ja) N-アルキルアミノ酸、およびn-アルキルアミノ酸を含むペプチドの製造方法
US12312379B2 (en) Methods for producing cyclic compounds comprising N-substituted amino acid residues
US12331072B2 (en) Deprotection method and resin removal method in solid-phase reaction for peptide compound or amide compound, and method for producing peptide compound
JP7766028B2 (ja) 高難度配列の効率的ペプチド縮合法
KR20250174064A (ko) 고리형 펩타이드 화합물의 제조 방법
CN116507624A (zh) 制备7-氯-6-氟-1-(2-异丙基-4-甲基吡啶-3-基)吡啶并f[2,3-d]嘧啶-2,4(1h,3h)-二酮的方法
CN114667136A (zh) Trofinetide的组合物
AU1947100A (en) Process for preparing growth hormone secretagogues
CN118475590A (zh) N-烷基氨基酸以及包含n-烷基氨基酸的肽的制造方法
JP7165289B1 (ja) N-置換アミノ酸残基を含む環状化合物の製造方法
HK40108253A (zh) N-烷基氨基酸以及包含n-烷基氨基酸的肽的制造方法
HK40096738A (zh) 包含n-取代氨基酸残基的环状化合物的制备方法
HK40080071A (en) Efficient peptide condensation method for difficult sequences
US20260001882A1 (en) Process for preparing bicyclic glycine-proline compounds and monocyclic glycine-proline intermediates thereof
HK40114205A (zh) 用於肽化合物或醯胺化合物的脱保护方法和在固相反应中的树脂脱除方法以及用於生产肽化合物的方法
EA049473B1 (ru) Композиции трофинетида
CN117279928A (zh) 包含n-取代氨基酸残基的环状化合物的制备方法
KR20110073473A (ko) 펩티드 화합물 및 그의 제조 방법
JPWO2001044165A1 (ja) (アミノメチル)トリフルオロメチルカルビノール誘導体の製造方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231107

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231107

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20231107

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231212

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231227

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240116

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240130

R150 Certificate of patent or registration of utility model

Ref document number: 7430297

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150